Rapamycin Makes the Ageing Cells Healthy Again, Claim Researchers
Progeria Syndrome can be treated in a more enhanced way, claims US researchers. These researchers got some cells of children who had grown old before time and made them strong again.
Rapamycin, also known as forever young drug, was developed from a chemical that is available on the soil of Easter Island. The drug is used in tests done on children suffering from Hutchinson-Gilford Progeria Syndrome
(HGPS), a state in which the child grows old at a high-strung temperament and dies due to old age at around 12 years.
HGPS roots a risky procedure where a protein called progerin develops in every cell of the body which leads to get older, prematurely.
Rapamycin scrubs the progerin cells and just leaves behind the healthy cells. It is used for suppressing the immune system in organ transplants.
One of the co-authors of the study, Dimitri Krainc said, “Our body’s ability to remove this debris declines with ageing and it is thought that even a small activation of this ‘debris removal’ system would extend the health and life-span of our cells and organs”. He said that, during ageing, the cells in human body builds up the by-products of normal cell function.
In an earlier research, the scientist had found that rapamycin has the power to increase the life span of humans for more than 10 years.
New Zealand News
- Tesla Model Y Performance becomes little bit more expensive to order in China
- Porsche’s recently unveiled Mission R Concept previews electric race cars of future
- Chinese manufacturer GAC’s Aion V e-SUV can charge 0-80% in just 8 minutes
- Oshidori International exits Japanese casino race, citing serious ethical irregularities
- CATL and LG Energy account for nearly 54% of global xEV battery market: SNE Research
- Micro Mobility shows off production version of Microlino 2.0 and 3-wheeled e-scooter
- Chinese electric motorcycle maker Evoke Motorcycles to set up shops in Spain
- TenneT adds more electric BMWs to study use of EVs to support power grids
- Italy’s ASPI announces plans to install cross-country ultra-fast EV charging network
- EV ownership costs significantly lower than conventional models: French Study